A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
- Resource Type
- Article
- Authors
- Hoyer, K.; Hablesreiter, R.; Inoue, Y.; Yoshida, K.; Briest, F.; Christen, F.; Kakiuchi, N.; Yoshizato, T.; Shiozawa, Y.; Shiraishi, Y.; Striefler, J.K.; Bischoff, S.; Lohneis, P.; Putter, H.; Blau, O.; Keilholz, U.; Bullinger, L.; Pelzer, U.; Hummel, M.; Riess, H.; Ogawa, S.; Sinn, M.; Damm, F.
- Source
- In eBioMedicine April 2021 66
- Subject
- Language
- ISSN
- 2352-3964